Frost & Sullivan Recognizes Transport Pharmaceuticals' Innovative Electrokinetic Drug Delivery Platform for Contributing to Clinical Outcomes.
Business Wire › December 10, 2007
Linked as:
Business Wire › December 10, 2007
Linked as:Extract
Frost & Sullivan Recognizes Transport Pharmaceuticals' Innovative Electrokinetic Drug Delivery Platform for Contributing to Clinical Outcomes.
PALO ALTO, Calif. -- Frost & Sullivan has presented Transport Pharmaceuticals, Inc. with the 2007 North American Technology Innovation of the Year Award in electrokinesis-enabled drug delivery in recognition of its development of a unique platfor...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
22 CFR 171.41 - Covered employees. | 29 CFR 4041A.44 - Cessation of withdrawal liability. | 39 USC 3662 Sec 3662 Rate and service complaints | util. l. rep. p 14,270 rio grande pipeline company, petitioner, v. federal energy regulatory commissio... | sentencia nº 2799 de consiglio di stato, may 11, 2011 | Sentencia nº 6742 de Consiglio di Stato December 19 2007 | Sentencia nº 1895 de Consiglio di Stato, April 20, 2009 | sentencia nº 2538 de consiglio di stato, june 05, 2010